Back to David Rubenstein
David Rubenstein → PHAT via Carlyle Group Inc.
David Rubenstein PHAT Position History
Phathom Pharmaceuticals, Inc. • Healthcare
Quarters held
14
Latest value
$37.9M
Q2 2026
Peak value
$63.2M
First seen
Q1 2023
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $37.9M | 3.50M | — | — |
| Q1 2026 | $38.8M | 3.50M | — | — |
| Q4 2025 | $58M | 3.50M | — | — |
| Q3 2025 | $41.1M | 3.50M | — | — |
| Q2 2025 | $33.5M | 3.50M | — | — |
| Q1 2025 | $21.9M | 3.50M | — | — |
| Q4 2024 | $28.4M | 3.50M | — | — |
| Q3 2024 | $63.2M | 3.50M | — | — |
| Q2 2024 | $35.8M | 3.50M | — | — |
| Q1 2024 | $37.1M | 3.50M | — | — |
| Q4 2023 | $31.9M | 3.50M | — | — |
| Q3 2023 | $36.2M | 3.50M | — | — |
| Q2 2023 | $50.1M | 3.50M | — | — |
| Q1 2023 | $20.9M | 2.94M | — | — |